Referenze
[1] Rauschmann et al. (2005), Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections, Biomaterials. 26(15):2677-2684.
[2] Englert et al. (2007), Konduktives Knochenersatzmaterial mit variabler Antibiotikaversetzung
[Conductive bone substitute material with variable antibiotic delivery], Unfallchirurg. 110(5):408-413.
[3] Standardized bulk volume, data on file at OSARTIS GmbH.
[4] von Stechow and Rauschmann (2009), Effectiveness of combination use of antibiotic-loaded PerOssal® with spinal surgery in patients with spondylodiscitis, Eur Surg Res. 43(3):298-305.
[5] Kraus und Schnettler (2008), Gutachten bei Osteitis [Expert opinion in osteitis], in: Bericht über die Unfallmedizinische Tagung in Mainz am 8./9.11.2008, Deutsche Gesetzliche Unfallversicherung (Hrsg.), Heft 108, ISBN 3-88383-082-8.
[6] Fleege et al. (2012), Systemische und lokale Antibiotikatherapie bei konservativ und operativ behandelten Spondylodiszitiden [Systemic and local antibiotic therapy of conservative and operative treatment of spondylodiscitis], Orthopäde. 41(9):727-735.
[7] Fleege and Rauschmann (2013), Duration of antibiotic therapy after surgical treatment of nonspecific spondylodiscitis. Preliminary trends from a prospective randomized study short-term vs.
long-term antibiotic therapy, 32. Annual Meeting of the European Bone & Joint Infection Society 2013.
[8] Fleege et al. (2017), Antibiotikatherapie der pyogenen Spondylodiszitis bei Erwachsenen
[Antibiotic therapy of pyogenic spondylodiscitis in adults], Die Wirbelsäule. 01(4):265.
[9] Release kinetic data on file at OSARTIS GmbH.
[10] Visani et al. (2018), Treatment of chronic osteomyelitis with antibiotic-loaded bone void filler systems:
an experience with hydroxyapatites calcium-sulfate biomaterials, Acta Orthop Belg. 84(1):25-29.